Vimarsana
Biggest News Aggregation in the World

Page 16 - Multidisciplinary Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multidisciplinary Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multidisciplinary Sciences Today - Breaking & Trending Today

BiondVax receives supportive Scientific Advice from the Paul Ehrlich Institute (PEI) for COVID-19 NanoAb development plans including first-in-human Phase 1/2a safety and efficacy clinical trial - Vimarsana News

BiondVax receives supportive Scientific Advice from the Paul Ehrlich Institute (PEI) for COVID-19 NanoAb development plans including first-in-human Phase 1/2a safety and efficacy clinical trial

PEI supports BiondVax's plan for first-in-human clinical trial to be conducted in patients as a combined Phase 1/2a, testing both safety and efficacy, thereby...

BiondVax Announces First Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

BiondVax Announces First Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceuticals company focused on developing, manufacturing and commercializing innovative...

New Method for the Accurate Measurement of Dopamine - Vimarsana News

New Method for the Accurate Measurement of Dopamine

Dopamine is a vital nerve cell signaling chemical. Until now, it was impossible to properly quantify its concentration with both high spatial and temporal resolution.

BiondVax to Present at H.C. Wainwright Global Investment Conference - Vimarsana News

BiondVax to Present at H.C. Wainwright Global Investment Conference

/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative...

BiondVax Provides Update at Biomed Israel Conference and Announces Significant Progress in its Nanosized Antibodies Program - Vimarsana News

BiondVax Provides Update at Biomed Israel Conference and Announces Significant Progress in its Nanosized Antibodies Program

/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative...